ANDA contains data which, when submitted to FDA’s Center for Drug Evaluation and Research, Office of Generic Drugs, provides for the review and ultimate approval of a generic drug product.
Apply now for the 2026 BLC Congressional Fellowship and join a growing bipartisan community of rising health policy leaders.